Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-Stage Lung Cancer Diagnosis

Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-Stage Lung Cancer Diagnosis

BackgroundLung cancer is a malignant tumor that has the highest morbidity and mortality rate among all cancers. Early diagnosis of lung cancer is a key factor in reducing mortality and improving prognosis.MethodsIn this study, we performed CTC next-generation sequencing (NGS) in early-stage lung can...

Full description

Bibliographic Details
Main Authors: Lingling Wan, Qingyi Liu, Di Liang, Yongdong Guo, Guangjie Liu, Jinxia Ren, Yutong He, Baoen Shan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
lung cancer
LC-MS untargeted metabolomics
circulating tumor cell
next-generation sequencing
diagnosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.630672/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.630672/full

Similar Items